Longevity science, genomic sequencing, and AI are reshaping modern healthcare — but the governance questions surrounding data ownership, equity, and regulatory oversight remain unresolved. This article examines the strategic, ethical, and institutional implications of personalised medicine's next frontier.

Despite heightened regional instability, UAE healthcare resilience continues to support strong investor and operator confidence. This article examines how governance clarity, national health security planning, pharmaceutical supply chain reform led by the Emirates Drug Establishment, and energy-backed infrastructure collectively sustain system stability and enable long-term healthcare investment in the UAE.